BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Bar-Moshe Y, Mazeh H, Grozinsky-Glasberg S. Non-functioning pancreatic neuroendocrine tumors: Surgery or observation? World J Gastrointest Endosc 2017; 9(4): 153-161 [PMID: 28465781 DOI: 10.4253/wjge.v9.i4.153]
URL: https://www.wjgnet.com/1948-5190/full/v9/i4/153.htm
Number Citing Articles
1
Min Yang, Lin Zeng, Wen-Qing Yao, Neng-wen Ke, Chun-lu Tan, Bo-le Tian, Xu-bao Liu, Bo Xiang, Yi Zhang. A comprehensive validation of the novel 8th edition of American Joint Committee on Cancer staging manual for the long-term survivals of patients with non-functional pancreatic neuroendocrine neoplasmsMedicine 2020; 99(46): e22291 doi: 10.1097/MD.0000000000022291
2
Bokyung Ahn, Joo Young Kim, Seung-Mo Hong. Combined Infiltrative Macroscopic Growth Pattern and Infiltrative Microscopic Tumor Border Status Is a Novel Surrogate Marker of Poor Prognosis in Patients With Pancreatic Neuroendocrine TumorArchives of Pathology & Laboratory Medicine 2023; 147(1): 100 doi: 10.5858/arpa.2021-0475-OA
3
C. G. Genc, H. J. Klümpen, M. G. H. van Oijen, C. H. J. van Eijck, E. J. M. Nieveen van Dijkum. A Nationwide Population‐Based Study on the Survival of Patients with Pancreatic Neuroendocrine Tumors in The NetherlandsWorld Journal of Surgery 2018; 42(2): 490 doi: 10.1007/s00268-017-4278-y
4
Jordan J. Baechle, Paula Marincola Smith, Marcus Tan, Carmen C. Solórzano, Alexandra G. Lopez-Aguiar, Mary Dillhoff, Eliza W. Beal, George Poultsides, Eleftherios Makris, Flavio G. Rocha, Angelena Crown, Clifford Cho, Megan Beems, Emily R. Winslow, Victoria R. Rendell, Bradley A. Krasnick, Ryan Fields, Shishir K. Maithel, Christina E. Bailey, Kamran Idrees. Specific Growth Rate as a Predictor of Survival in Pancreatic Neuroendocrine Tumors: A Multi-institutional Study from the United States Neuroendocrine Study GroupAnnals of Surgical Oncology 2020; 27(10): 3915 doi: 10.1245/s10434-020-08497-4
5
Reto M. Kaderli, Dietmar Simon. Endocrine Surgery Comprehensive Board Exam Guide2021; : 695 doi: 10.1007/978-3-030-84737-1_28
6
Farzad Rahmani, Amir Avan. Recent Advances in Nanocarriers for Pancreatic Cancer Therapy2024; : 3 doi: 10.1016/B978-0-443-19142-8.00006-1
7
Alexander W. Coombs, Chloe Jordan, Sabba A. Hussain, Omar Ghandour. Scoring systems for the management of oncological hepato-pancreato-biliary patientsAnnals of Hepato-Biliary-Pancreatic Surgery 2022; 26(1): 17 doi: 10.14701/ahbps.21-113
8
Bartosz Molasy, Patryk Zemła, Sławomir Mrowiec, Ewa Grudzińska, Katarzyna Kuśnierz. Evaluation of Risk Factors for Distant and Lymph Node Metastasis of Pancreatic Neuroendocrine TumorsTherapeutics and Clinical Risk Management 2022; : 745 doi: 10.2147/TCRM.S361332
9
Marina Gorelik, Mahmoud Ahmad, David Grossman, Martin Grossman, Avram M. Cooperman. Nonfunctioning Incidental Pancreatic Neuroendocrine TumorsSurgical Clinics of North America 2018; 98(1): 157 doi: 10.1016/j.suc.2017.09.014
10
Application of low dose pancreas perfusion CT combined with enhancement scanning in diagnosis of pancreatic neuroendocrine tumorsPancreatology 2021; 21(1): 240 doi: 10.1016/j.pan.2020.10.046
11
Estela Regina Ramos Figueira, Julia Fray Ribeiro, Thiago Costa Ribeiro, Ricardo Jureidini, Guilherme Naccache Namur, Thiago Nogueira Costa, Telesforo Bacchella, Ivan Cecconello, Jose Celso Ardengh. Insights of Outcome after Resection of Small Nonfunctioning Neuroendocrine Pancreatic TumorsGastroenterology Research and Practice 2021; 2021: 1 doi: 10.1155/2021/6650386
12
Wenchao Gu, Yingli Chen, Haibin Zhu, Haidi Chen, Zongcheng Yang, Shaocong Mo, Hongyue Zhao, Lei Chen, Takahito Nakajima, XianJun Yu, Shunrong Ji, YaJia Gu, Jie Chen, Wei Tang. Development and validation of CT-based radiomics deep learning signatures to predict lymph node metastasis in non-functional pancreatic neuroendocrine tumors: a multicohort studyeClinicalMedicine 2023; 65: 102269 doi: 10.1016/j.eclinm.2023.102269
13
Julie M. Guilmette, Vania Nosé. Neoplasms of the Neuroendocrine Pancreas: An Update in the Classification, Definition, and Molecular Genetic AdvancesAdvances in Anatomic Pathology 2019; 26(1): 13 doi: 10.1097/PAP.0000000000000201
14
Praveen Dilip Chatani, Sunita Kishore Agarwal, Samira Mercedes Sadowski. Molecular Signatures and Their Clinical Utility in Pancreatic Neuroendocrine TumorsFrontiers in Endocrinology 2021; 11 doi: 10.3389/fendo.2020.575620
15
Patrick W. Underwood, Andrea N. Riner, Dan Neal, Miles E. Cameron, Anastasiya Yakovenko, Sushanth Reddy, John Bart Rose, Steven J. Hughes, Jose G. Trevino. It's more than just cancer biology: Health disparities in patients with pancreatic neuroendocrine tumorsJournal of Surgical Oncology 2021; 124(8): 1390 doi: 10.1002/jso.26667
16
Jordan J. Baechle, Paula Marincola Smith, Kamran Idrees. ASO Author Reflections: Elevated Preoperative Specific Growth Rate is Associated with Shortened Survival After Resection for Pancreatic Neuroendocrine TumorsAnnals of Surgical Oncology 2020; 27(10): 3924 doi: 10.1245/s10434-020-08527-1
17
Zu-Yi Ma, Yuan-Feng Gong, Hong-Kai Zhuang, Zi-Xuan Zhou, Shan-Zhou Huang, Yi-Ping Zou, Bo-Wen Huang, Zhong-Hai Sun, Chuan-Zhao Zhang, Yun-Qiang Tang, Bao-Hua Hou. Pancreatic neuroendocrine tumors: A review of serum biomarkers, staging, and managementWorld Journal of Gastroenterology 2020; 26(19): 2305-2322 doi: 10.3748/wjg.v26.i19.2305